Back

Agomab shareholders approve board appointments and pre-IPO warrant adjustment

Verifying
  • Agomab shareholders approved two non-executive Board appointments and pre-IPO warrant adjustments.
  • September 11, 2026 marked the Special and Extraordinary General Shareholders' Meeting.
  • The warrant adjustment aligns outstanding pre-IPO warrants with Agomab's February 2026 IPO share split.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.